MedPath

Exploratory Study of "Natural Killer" Inflammatory Lymphocytes in Waste Per-operating of Tonsillectomy

Completed
Conditions
Tonsillectomy
Registration Number
NCT03311919
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The aim of this study is to describe the frequency of the presence of cells Natural Killer (NK) expressing CD86 and HLA - DR in tonsils

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • patient with programmed tonsillectomy as part of the care
Exclusion Criteria
  • patient opposition to use its waste of per-operating tonsillectomy for research purposes
  • patient with immunosuppressive and/or corticoid treatment (> 1 mg/kg)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
presence of lymphocytes NK expressing CD86 and HLA - DRinclusion

by immunostaining and detection by flow cytometry

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath